Transforming the Cosmetic Contact Lens Business into a B2C Brand Manufacturer and Expanding in the Chinese Market
First written in FY2019. 2 of 13 entries say "Restated". Latest entry: FY2025.
Shobido moved to the "Worse" side of this theme in 2024.
0 other companies' latest entry also says "Materialised".
- FY2025MaterialisedAnnual report
「Contact lens-related sales decreased significantly year on year to ¥2,244.395 million, down 10.5%, due to the impact of the withdrawal from the contact lens e-commerce business at the Chinese subsidiary during the previous consolidated fiscal year.」
The impact of the withdrawal from the Chinese contact lens e-commerce business was reflected in full-year sales, and contact lens-related sales decreased 10.5%. - FY2025-H1MaterialisedAnnual report
「Net sales for the current interim consolidated accounting period fell sharply to ¥1,072.704 million, down 24.1% year on year, due to the withdrawal of the Chinese second-tier subsidiary from the contact lens e-commerce business.」
The policy of scaling back and withdrawing from the Chinese contact lens e-commerce business was reflected in actual business sales, which decreased 24.1%. - FY2024-Q1SoftenedAnnual report
「We opened a flagship store on Tmall in China and worked to expand contact lens sales through B2C e-commerce sites. However, in response to intensifying price competition and the global spread of COVID-19, we decided to transfer 41% of the 51% interest in 壹見 held by Shanghai SHOBIDO to 杭州悠可化粧品有限公司 and 戴氏.」
Under the policy of expanding B2C and e-commerce operations in China, the transfer of 41% of 壹見's 51% interest was carried out on 2 January 2024, moving the reduction of the business and the selection and concentration of management resources into the execution stage. - FY2023SoftenedAnnual report
「We opened a flagship store on Tmall in China and worked to expand contact lens sales through B2C e-commerce sites. However, in response to intensifying price competition and the global spread of COVID-19, we decided to transfer 41% of the 51% interest in 壹見 held by Shanghai SHOBIDO to 杭州悠可化粧品有限公司 and 戴氏.」
Against the policy of expanding B2C and e-commerce operations in China, the Company shifted to a policy of transferring 41% of its interest in 壹見 because of price competition and the impact of the pandemic. The transfer was scheduled for 29 December 2023 and had not been completed as of the filing date. - FY2023-Q3Domestic growth alongside the impact of the Chinese marketAnnual report
「Net sales for the first nine months of the current consolidated fiscal year amounted to ¥1,811.132 million, down 2.8% year on year. The Company secured higher sales in the domestic market, but sales declined due to the impact of lockdowns in China and intensifying competition with local manufacturers.」
While domestic sales increased, lockdowns in China and intensifying competition with local manufacturers continued, and overall contact lens-related sales decreased. - FY2023-Q2Domestic growth alongside the impact of the Chinese marketAnnual report
「Net sales for the first six months of the current consolidated fiscal year amounted to ¥1,267.400 million, up 3.5% year on year. The Company secured substantial sales growth in the domestic market despite the impact of lockdowns in overseas markets, particularly China.」
While domestic sales increased significantly, the impact of lockdowns remained in China, and overall contact lens-related sales increased 3.5%. - FY2023-Q1Overall sales increased amid domestic growth and the impact of the Chinese marketAnnual report
「Net sales for the first three months of the current consolidated fiscal year amounted to ¥629.493 million, up 6.0% year on year. The Company secured substantial sales growth in the domestic market despite the impact of lockdowns in overseas markets, particularly China.」
Domestic sales increased significantly, and overall contact lens-related sales also increased 6.0%. Meanwhile, the impact of lockdowns continued in China. - FY2022Domestic recovery alongside China's lockdowns and intensifying competitionAnnual report
「Demand for contact lenses in Japan recovered in both the B2B and B2C markets, while the Chinese market was affected by lockdowns and intensifying competition with Chinese companies, resulting in overall sales of ¥2,521.679 million, down 6.2% year on year.」
While B2B and B2C demand recovered in Japan, lockdowns in China and intensifying competition with local companies occurred, and no recovery in Chinese market demand was confirmed despite the policy of overseas expansion. - FY2022-Q3Overseas demand remained unrecovered due to China's lockdownsAnnual report
「Net sales for the first nine months of the current consolidated fiscal year edged down 1.1% year on year to ¥1,864.046 million. The Company secured higher sales in the domestic market, as it did in cosmetics and cosmetic accessories, following the easing of restrictions on activities, but overseas demand did not recover due to the impact of lockdowns in China, the main market, among other factors.」
While domestic sales increased, overseas demand did not recover because of lockdowns in China and other factors, and no recovery in demand has been confirmed for the overseas expansion of cosmetic contact lenses. - FY2021RestatedAnnual report
「In Japan, to establish our brand as a Japanese contact lens manufacturer, we will strengthen marketing for the brands developed by our group and seek to expand e-commerce sales by increasing the presence of our branded products in the B2C market. In overseas markets, with China and the broader Chinese-speaking market as our primary focus, where populations are large and contact lens adoption is expected to increase further, we will leverage the brand strength we have built domestically as a Japanese contact lens manufacturer, focusing on acquiring SHOBIDO fans and expanding e-commerce sales.」
The Company has continued its policy of expanding B2C brands and e-commerce sales in Japan, and e-commerce sales centered on China and the broader Chinese-speaking market overseas. - FY2021-Q2RestatedAnnual report
「Net sales for the first six months of the current consolidated fiscal year amounted to ¥1,291.381 million, down 13.2% year on year. Contact lens sales overseas continued to trend upward, but demand for contact lenses remained weak in Japan as consumers continued to refrain from going out.」
The Company is experiencing both overseas growth in contact lens sales and weak domestic demand, and has continued its policy of expanding in China and other overseas markets. - FY2020-Q3AdvancedAnnual report
「Net sales for the first nine months of the current consolidated fiscal year amounted to ¥2,093.705 million, down 11.8% year on year. Sales in China and of clear lenses increased, but demand for daily disposable colored lenses remained weak as consumers refrained from going out, while the Company continued to select and concentrate its contact lens product brands and customers.」
Sales in China increased, indicating concrete progress related to the policy of expanding in the Chinese market. However, overall contact lens-related sales decreased because of weak demand for daily disposable colored lenses and the selection and concentration of products and customers. - FY2019First statedAnnual report
「However, in light of the fact that synergies with the existing business have not emerged to the extent initially expected, we have changed our policy to substantially scale back the wholesale business and expand sales to end consumers by positioning ourselves as a brand manufacturer. In Japan, going forward, to establish our brand as a Japanese contact lens manufacturer, we will narrow the brands developed by our group to PienAge® and Decorative Eyes®, among others, and strengthen marketing to enhance their value. To expand sales in this business, we will actively increase sales of products whose brand strength has been enhanced in Japan, targeting China and the broader Chinese-speaking market, where populations are large and contact lens adoption is expected to increase.」
For the cosmetic contact lens business, the Company newly stated its policy of substantially scaling back its existing wholesale business and transitioning to a consumer-facing brand manufacturer. Specific measures include narrowing its domestic brands, strengthening marketing, and expanding sales in China and the broader Chinese-speaking market.